197 related articles for article (PubMed ID: 31102405)
1. A genome-wide association study identifies susceptibility loci for primary central nervous system lymphoma at 6p25.3 and 3p22.1: a LOC Network study.
Labreche K; Daniau M; Sud A; Law PJ; Royer-Perron L; Holroyd A; Broderick P; Went M; Benazra M; Ahle G; Soubeyran P; Taillandier L; Chinot OL; Casasnovas O; Bay JO; Jardin F; Oberic L; Fabbro M; Damaj G; Brion A; Mokhtari K; Philippe C; Sanson M; Houillier C; Soussain C; Hoang-Xuan K; Houlston RS; Alentorn A;
Neuro Oncol; 2019 Aug; 21(8):1039-1048. PubMed ID: 31102405
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma.
Cerhan JR; Berndt SI; Vijai J; Ghesquières H; McKay J; Wang SS; Wang Z; Yeager M; Conde L; de Bakker PI; Nieters A; Cox D; Burdett L; Monnereau A; Flowers CR; De Roos AJ; Brooks-Wilson AR; Lan Q; Severi G; Melbye M; Gu J; Jackson RD; Kane E; Teras LR; Purdue MP; Vajdic CM; Spinelli JJ; Giles GG; Albanes D; Kelly RS; Zucca M; Bertrand KA; Zeleniuch-Jacquotte A; Lawrence C; Hutchinson A; Zhi D; Habermann TM; Link BK; Novak AJ; Dogan A; Asmann YW; Liebow M; Thompson CA; Ansell SM; Witzig TE; Weiner GJ; Veron AS; Zelenika D; Tilly H; Haioun C; Molina TJ; Hjalgrim H; Glimelius B; Adami HO; Bracci PM; Riby J; Smith MT; Holly EA; Cozen W; Hartge P; Morton LM; Severson RK; Tinker LF; North KE; Becker N; Benavente Y; Boffetta P; Brennan P; Foretova L; Maynadie M; Staines A; Lightfoot T; Crouch S; Smith A; Roman E; Diver WR; Offit K; Zelenetz A; Klein RJ; Villano DJ; Zheng T; Zhang Y; Holford TR; Kricker A; Turner J; Southey MC; Clavel J; Virtamo J; Weinstein S; Riboli E; Vineis P; Kaaks R; Trichopoulos D; Vermeulen RC; Boeing H; Tjonneland A; Angelucci E; Di Lollo S; Rais M; Birmann BM; Laden F; Giovannucci E; Kraft P; Huang J; Ma B; Ye Y; Chiu BC; Sampson J; Liang L; Park JH; Chung CC; Weisenburger DD; Chatterjee N; Fraumeni JF; Slager SL; Wu X; de Sanjose S; Smedby KE; Salles G; Skibola CF; Rothman N; Chanock SJ
Nat Genet; 2014 Nov; 46(11):1233-8. PubMed ID: 25261932
[TBL] [Abstract][Full Text] [Related]
3. MYC, BCL2, and BCL6 rearrangements in primary central nervous system lymphoma of large B cell type.
Nosrati A; Monabati A; Sadeghipour A; Radmanesh F; Safaei A; Movahedinia S
Ann Hematol; 2019 Jan; 98(1):169-173. PubMed ID: 30306208
[TBL] [Abstract][Full Text] [Related]
4. Tracking the Genetic Susceptibility Background of B-Cell Non-Hodgkin's Lymphomas from Genome-Wide Association Studies.
Hernández-Verdin I; Labreche K; Benazra M; Mokhtari K; Hoang-Xuan K; Alentorn A
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374413
[TBL] [Abstract][Full Text] [Related]
5. Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System Lymphomas.
Braggio E; Van Wier S; Ojha J; McPhail E; Asmann YW; Egan J; da Silva JA; Schiff D; Lopes MB; Decker PA; Valdez R; Tibes R; Eckloff B; Witzig TE; Stewart AK; Fonseca R; O'Neill BP
Clin Cancer Res; 2015 Sep; 21(17):3986-94. PubMed ID: 25991819
[TBL] [Abstract][Full Text] [Related]
6. Genetic susceptibility to diffuse large B-cell lymphoma in a pooled study of three Eastern Asian populations.
Bassig BA; Cerhan JR; Au WY; Kim HN; Sangrajrang S; Hu W; Tse J; Berndt S; Zheng T; Zhang H; Pornsopone P; Lee JJ; Kim HJ; Skibola CF; Vijai J; Burdette L; Yeager M; Brennan P; Shin MH; Liang R; Chanock S; Lan Q; Rothman N
Eur J Haematol; 2015 Nov; 95(5):442-8. PubMed ID: 25611436
[TBL] [Abstract][Full Text] [Related]
7. Array-based profiling of the lymphoma cell DNA methylome does not unequivocally distinguish primary lymphomas of the central nervous system from non-CNS diffuse large B-cell lymphomas.
Vogt J; Wagener R; Montesinos-Rongen M; Ammerpohl O; Paulus W; Deckert M; Siebert R
Genes Chromosomes Cancer; 2019 Jan; 58(1):66-69. PubMed ID: 30284345
[TBL] [Abstract][Full Text] [Related]
8. [Perspectives on Precision Medicine in Primary Central Nervous System Lymphoma].
Sasaki N; Nagane M
No Shinkei Geka; 2022 Jan; 50(1):51-60. PubMed ID: 35169086
[TBL] [Abstract][Full Text] [Related]
9. Pathway analysis of primary central nervous system lymphoma.
Tun HW; Personett D; Baskerville KA; Menke DM; Jaeckle KA; Kreinest P; Edenfield B; Zubair AC; O'Neill BP; Lai WR; Park PJ; McKinney M
Blood; 2008 Mar; 111(6):3200-10. PubMed ID: 18184868
[TBL] [Abstract][Full Text] [Related]
10. Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas.
Ferreri AJ; Dell'Oro S; Capello D; Ponzoni M; Iuzzolino P; Rossi D; Pasini F; Ambrosetti A; Orvieto E; Ferrarese F; Arrigoni G; Foppoli M; Reni M; Gaidano G
Br J Haematol; 2004 Sep; 126(5):657-64. PubMed ID: 15327516
[TBL] [Abstract][Full Text] [Related]
11. A clinicopathological study of primary central nervous system lymphomas & their association with Epstein-Barr virus.
Sharma MC; Gupta RK; Kaushal S; Suri V; Sarkar C; Singh M; Kale SS; Sahoo RK; Kumar L; Raina V
Indian J Med Res; 2016 May; 143(5):605-15. PubMed ID: 27488004
[TBL] [Abstract][Full Text] [Related]
12. Whole-Exome Sequencing Revealed the Mutational Profiles of Primary Central Nervous System Lymphoma.
Zhang R; Wei B; Hu Y; Lv W; Adilai A; Yang F; Zhang J; Cheng G
Clin Lymphoma Myeloma Leuk; 2023 Apr; 23(4):291-302. PubMed ID: 36725383
[TBL] [Abstract][Full Text] [Related]
13. Mutational analysis of primary central nervous system lymphoma.
Bruno A; Boisselier B; Labreche K; Marie Y; Polivka M; Jouvet A; Adam C; Figarella-Branger D; Miquel C; Eimer S; Houillier C; Soussain C; Mokhtari K; Daveau R; Hoang-Xuan K
Oncotarget; 2014 Jul; 5(13):5065-75. PubMed ID: 24970810
[TBL] [Abstract][Full Text] [Related]
14. Expression of immunoglobulin transcription factors in primary intraocular lymphoma and primary central nervous system lymphoma.
Coupland SE; Loddenkemper C; Smith JR; Braziel RM; Charlotte F; Anagnostopoulos I; Stein H
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):3957-64. PubMed ID: 16249468
[TBL] [Abstract][Full Text] [Related]
15. Primary central nervous system diffuse large B-cell lymphoma has poorer immune cell infiltration and prognosis than its peripheral counterpart.
Chang C; Lin CH; Cheng AL; Medeiros LJ; Chang KC
Histopathology; 2015 Nov; 67(5):625-35. PubMed ID: 25829022
[TBL] [Abstract][Full Text] [Related]
16. Preferential up-regulation of osteopontin in primary central nervous system lymphoma does not correlate with putative receptor CD44v6 or CD44H expression.
Yuan J; Gu K; He J; Sharma S
Hum Pathol; 2013 Apr; 44(4):606-11. PubMed ID: 23089492
[TBL] [Abstract][Full Text] [Related]
17. Rare cases of primary central nervous system anaplastic variant of diffuse large B-cell lymphoma.
Xu T; Jia Q; Wang Y; Liu Y; Han D; Li P; Ma J; Fan L; Yan Q; Guo S; Li M; Wang Z
Diagn Pathol; 2019 May; 14(1):45. PubMed ID: 31109360
[TBL] [Abstract][Full Text] [Related]
18. Characterization of genomic alterations in primary central nervous system lymphomas.
Zorofchian S; El-Achi H; Yan Y; Esquenazi Y; Ballester LY
J Neurooncol; 2018 Dec; 140(3):509-517. PubMed ID: 30171453
[TBL] [Abstract][Full Text] [Related]
19. The genomic and transcriptional landscape of primary central nervous system lymphoma.
Radke J; Ishaque N; Koll R; Gu Z; Schumann E; Sieverling L; Uhrig S; Hübschmann D; Toprak UH; López C; Hostench XP; Borgoni S; Juraeva D; Pritsch F; Paramasivam N; Balasubramanian GP; Schlesner M; Sahay S; Weniger M; Pehl D; Radbruch H; Osterloh A; Korfel A; Misch M; Onken J; Faust K; Vajkoczy P; Moskopp D; Wang Y; Jödicke A; Trümper L; Anagnostopoulos I; Lenze D; Küppers R; Hummel M; Schmitt CA; Wiestler OD; Wolf S; Unterberg A; Eils R; Herold-Mende C; Brors B; ; Siebert R; Wiemann S; Heppner FL
Nat Commun; 2022 May; 13(1):2558. PubMed ID: 35538064
[TBL] [Abstract][Full Text] [Related]
20. Systems biology of primary CNS lymphoma: from genetic aberrations to modeling in mice.
Deckert M; Montesinos-Rongen M; Brunn A; Siebert R
Acta Neuropathol; 2014 Feb; 127(2):175-88. PubMed ID: 24240734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]